"We are very proud that the Milliflex Quantum has placed as a finalist in the prestigious 2012 American Business Awards", said Roland Heinrich Ph.D., Vice President for BioMonitoring in EMD Millipore's Lab Solutions Business Unit. "We work collaboratively with our customers and this recognition further affirms our commitment to deliver state-of-the art, easy-to-use products that result in reduced cycle times for microbiological control laboratories."
The Milliflex® Quantum system is ideal for testing raw material, in-process samples, final product and environmental samples. It is non-destructive, an important feature that enables operators to grow microorganisms in order to identify them with standard ID technology.
The product is traditionally used in the following markets: pharmaceutical non-sterile and sterile products, active pharmaceutical ingredients, biopharmaceutical processes and serum/plasma manufacturing. In addition, the product can be used in soft drink testing, drinking water testing, brewery and cider microbiological testing.
More than 3,000 nominations from organizations of all sizes and in virtually every industry were submitted to The American Business Awards for consideration in a wide range of categories, including Most Innovative Company of the Year, Management Team of the Year, Best New Product or Service of the Year, Corporate Social Responsibility Program of the Year, and Executive of the Year, among others. EMD Millipore’s Milliflex® Quantum is a finalist in the New Product of the Year category for Business-to-Business Product s and will ultimately receive either a Gold, Silver or Bronze “Stevie” Award in a ceremony to be held in San Francisco on September 17.
Details about The American Business Awards and the list of Finalists in all categories are available at www.stevieawards.com/aba.
For more information about the EMD Millipore Milliflex Quantum product, go to
www.millipore.com/process_monitoring/cp1/milliflex_quantum.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
About Merck
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merck.de/subscribe to register online, change your selection or discontinue this service.
Merck is a global pharmaceutical and chemical company with total revenues of € 10.3 billion in 2011, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
About the Stevie Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about The Stevie Awards at www.stevieawards.com.
